Evidence map›Paper›PMID 19812566›Full record

ArticleNature medicine2009

Preserving fertility during cancer treatment.

Teresa K Woodruff

Abstract readCommentNews
In one paragraph

Article in Nature medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.Journal of the National Comprehensive Cancer Network : JNCCN · 2018
    Pooled it
  2. Article
  3. Article
  4. A synopsis of global frontiers in fertility preservation.Journal of assisted reproduction and genetics · 2022
    Review
  5. Preserving Oocytes in Oncofertility†.Biology of reproduction · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Clinical medicine insights. Reproductive health · 2019
    Review
  10. Review
  11. Article
  12. Article
  13. A win-win for women's reproductive health: A nonsteroidal contraceptive and fertoprotective neoadjuvant.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The p53 family: guardians of maternal reproduction.Nature reviews. Molecular cell biology · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Teresa K Woodruff

Funding

U54: The Oncofertility Consortium: Fertility Preservation for Woman (1 of 10)UL1DE019587 · NIDCR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2008 to 2011
$3.7M
NIDCR NIH HHS UL1 DE019587
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsApoptosisBenzamidesCisplatinFemaleHumansImatinib MesylateInfertility, FemaleMicePiperazinesPrimary Ovarian InsufficiencyPyrimidinesAntineoplastic AgentsBenzamidesCisplatinImatinib MesylatePiperazinesPyrimidines

Identifiers

PMID19812566
PMCPMC3124896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.